Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
Pyridoxamine (BioStratum)Nick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Fidarestat. Sanwa Kagaku/NC Curex/SankyoNick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
DiaPep277 (DeveloGen)Nick GiannoukakisImmunotherapy|September 4, 2013
Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie LockwoodNick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Exenatide. Amylin/Eli LillyNick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|October 2, 2007
BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analogNick GiannoukakisIdrugs : the Investigational Drugs Journal|June 12, 2003
NBI-6024 (Neurocrine Biosciences)Nick GiannoukakisCurrent Opinion in Investigational Drugs (London, England : 2000)|November 8, 2006
Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complicationsNick GiannoukakisCardiovascular Diabetology|July 13, 2022
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonistBrett E Phillips, Louise Lantier, Carl Engman, et al.Pageof 9